Radiotherapy and chemotherapy in the conservative treatment of anal canal carcinoma

Anticancer Research

Volumn 28, Issue 2 B, 2008, Pages 1335-1339

  Raffetto, Nicola ^a   Monaco, Alessia ^a,b   Banelli, Enzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Anal canal carcinoma; Chemotherapy; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ANUS CARCINOMA; ANUS SPHINCTER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; DIARRHEA; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SKIN TOXICITY; SURVIVAL TIME; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MITOMYCIN; NEOPLASM STAGING; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES;

EID: 42549131839     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Klas JV, Rothenberger DA, Wong Wd and Madoff RD: Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 85: 1686-1693, 1999.
2. Ryan DP, Compton CC and Mayer RJ: Carcinoma of the anal canal. N Engl J Med 342: 792-800, 2000.
3. Nigro ND, Vaitkevicius VK and Considine B: Combined therapy for cancer of the anal canal: A preliminary report. Dis Colon Rectum 17: 354-356, 1974.
4. Myerson RJ, Karnell LH and Menck HR: The national cancer data base report on carcinoma of the anus. Cancer 80: 805-815, 1997.
5. Nigro ND: Multidisciplinary management of cancer of the anus. World J Surg 11: 446-451, 1987.
6. Sobin LH and Fleming ID: TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803-1804, 1997.
7. Chavaudra J: Last ICRU recommendations for the prescription, recording and reporting of external bean therapy. Cancer Radiother 2: 607-614, 1998.
8. International Commission on Radiation Units and Measurement: Dose Specification for Reporting External Beam Therapy with Photons and Electrons. ICRU report 29, 1978.
9. Cox JD, Stetz J and Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31: 1341-1346, 1995.
10. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS and Catton CN: Epidermoid anal cancer. Treatment by radiation alone or by 5-fluorouracil with and without mitomycin-c. Int J Radiat Oncol Biol Phys 21: 1115-1125, 1991.
11. Smith DE, Shah KH, Rao AR, Frost DB, Latino F, Anderson PJ, Peddada AV and Kagan AR: Cancer of the anal canal: Treatment with chemotherapy and low dose radiation therapy. Radiology 191: 569-572, 1994.
12. Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS and DeLaney TF: Dose-time considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 39: 651-657, 1997.
13. Allal AS, Mermillod B, Roth AD, Marti MC and Kurtz JM: The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer 79: 2329-2335, 1997.
14. John M, Pajak T, Flam M, Hoffman J, Markoe A, Wolkov H and Paris K: Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08. Cancer J Sci Am 2: 205-211, 1996.
15. Martenson JA, Lipsitz SR, Wagner H Jr, Kaplan EH, Otteman LA, Schuchter LM, Mansour EG, Talamonti MS and Benson AB 3rd: Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An Eastern Cooperative Oncology Group Study. Int J Radiat Oncol Biol Phys 35: 745-757, 1996.
16. Ferrigno R, Nakamura RA, Dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV, Filho WJ and Lopes A: Radiochemotherapy in the conservative treatment of anal canal carcinoma: Retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 61: 1136-1142, 2005.
17. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M and Pierart M: Radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol 15: 2040-2049, 1997.
18. Peiffert D, Bey P, Pernot M, Guillemin F, Luporsi E, Hoffstetter S, Aletti P, Boissel P, Bigard MA, Dartois D and Baylac F: Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumor control and complications. Int J Radiat Oncol Biol Phys 37: 313-324, 1997.
19. Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Houry S, Gallot D, Parc R, Huang R, Qu SH, Huart J, Pêne F and Schlienger M: Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 56: 1259-1273, 2003.
20. Ortholan C, Ramaioli A, Peiffert D, Lusinchi A, Romestaing P, Chauveinc L, Touboul E, Peignaux K, Bruna A, de La Roche G, Lagrange JL, Alzieu C and Gerard JP: Anal Canal Carcinoma: early-stage tumors ≤10 mm (T1 or Tis): Therapeutic options and original pattern of local failure after radiotherapy. Int J Radiat Oncol Biol Phys 62: 479-485, 2005.
21. Vuong T, Devic 1, Belliveau P, Muanza T and Hegyi G: Contribution of conformai therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: Results of a phase II study. Int J Radiat Oncol Biol Phys 56: 823-831, 2003.
22. Gerard JP, Chapet O, Samiei F, Morignat E, Isaac S, Paulin C, Romestaing P, Favrel V, Mornex F and Bobin JY: Management of inguinal lymph node metastases in patient with carcinoma of the anal canal. Cancer 92: 77-84, 2001.
23. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L and Murray K: Role of Mitomycina in combination with fluorouracil and radiotherapy and of salvage chemoradiation in the definitive non surgical treatment of epidermoid carcinoma of the anal canal: results of a Phase III randomized intergroup study. J Clin Oncol 14: 2527-2539, 1996.
24. Gerard JP, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet JM and Mornex F: Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 46: 249-256, 1998.
25. Allal AS, Laurencet FM, Reymond MA, Kurtz JM and Marti MC: Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter conserving treatment. Cancer 86: 405-409, 1999.
26. Touboul E, Schlienger M, Buffat L, Lefkopoulos D, Pène F, Parc R, Tiret E, Gallot D, Malafosse M and Laugier A: Epidermoid carcinoma of the anal canal: Results of curative-intent radiotherapy in a series of 270 patients. Cancer 73: 1569-1579, 1994.
27. Mullen JT, Rodriguez-Bigas MA, Chang GJ, Barcenas CH, Crane CH, Skibber JM and Feig BW: Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol 14: 478-483, 2007.
28. Huang K, Haas-Kogan D, Weinberg V and Krieg R: Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal. World J Gastroenterol 14: 895-900, 2007.
29. Sato H, Koh P-K and Bartolo DC: Management of anal canal cancer. Dis Colon Rectum 48: 1301-1315, 2005.
30. Damin DC, Rosito MA and Schwartsmann G: Sentinel lymph node in carcinoma of the anal canal: a review. EJSO 32: 247-252, 2006.
31. Ulmer C, Bembenek A, Gretschel S, Markwardt J, Koswig S, Schneider U and Schlag PM: Refined staging by sentinel lymph node biopsy to individualize therapy in anal cancer. Ann Surg Oncol 11: 259S-262S, 2004.
32. Perera D, Pathma-Nathan N, Rabbitt P, Hewett P and Rieger N: Sentinel node biopsy for squamous-cell carcinoma of the anus and anal margin. Dis Colon Rectum 46: 1027-1031, 2003.